- Home
- LGTY vs RNAC Comparison
LGTY vs RNAC Comparison
Compare LGTY & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGTY
- RNAC
- Stock Information
- Founded
- LGTY 1970
- RNAC 2007
- Country
- LGTY United States
- RNAC United States
- Employees
- LGTY N/A
- RNAC N/A
- Industry
- LGTY
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- LGTY
- RNAC Health Care
- Exchange
- LGTY NYSE
- RNAC Nasdaq
- Market Cap
- LGTY 501.6M
- RNAC 496.8M
- IPO Year
- LGTY N/A
- RNAC 2016
- Fundamental
- Price
- LGTY $14.08
- RNAC $19.24
- Analyst Decision
- LGTY Hold
- RNAC Strong Buy
- Analyst Count
- LGTY 1
- RNAC 8
- Target Price
- LGTY N/A
- RNAC $41.67
- AVG Volume (30 Days)
- LGTY 727.6K
- RNAC 57.6K
- Earning Date
- LGTY 02-20-2025
- RNAC 03-06-2025
- Dividend Yield
- LGTY 3.13%
- RNAC N/A
- EPS Growth
- LGTY N/A
- RNAC N/A
- EPS
- LGTY 0.10
- RNAC N/A
- Revenue
- LGTY $101,873,000.00
- RNAC $47,938,000.00
- Revenue This Year
- LGTY $1.99
- RNAC $56.02
- Revenue Next Year
- LGTY $3.46
- RNAC N/A
- P/E Ratio
- LGTY $147.14
- RNAC N/A
- Revenue Growth
- LGTY N/A
- RNAC N/A
- 52 Week Low
- LGTY $8.41
- RNAC $11.67
- 52 Week High
- LGTY $14.20
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- LGTY N/A
- RNAC 51.12
- Support Level
- LGTY N/A
- RNAC $19.22
- Resistance Level
- LGTY N/A
- RNAC $20.00
- Average True Range (ATR)
- LGTY 0.00
- RNAC 0.85
- MACD
- LGTY 0.00
- RNAC 0.04
- Stochastic Oscillator
- LGTY 0.00
- RNAC 67.10
About LGTY LOGILITY SUPPLY CHAIN SOLUTIONS INC
Logility Supply Chain Solutions Inc develops enterprise management and supply chain-related software and services. Its Services include Scenario Planning Products, Demand Planning InventoryAI+, Supply, Deployment, Supply Chain Data Management, and Supply Chain Design. The group provides services to various industries such as Food and Beverage Consumer Packaged Goods, Process Manufacturing, Industrial Manufacturing, Chemicals, and others.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.